University of Michigan Board of Regents Minutes 2026-03-19
Michigan Biomedical Venture Fund Invests in Enexa Bio
Trusted by teams at
Description
The Regents approved execution of investment agreements between the Michigan Biomedical Venture Fund and Enexa Bio, Inc., granting the University equity and future purchase rights in the biomedical startup. The venture capital agreements follow standard terms and include conflict-of-interest oversight for a UM employee affiliate.
Contract Details
Vendor
ENEXA BIO INC
Agency
University Of Michigan-Ann Arbor, MI
Contract Type
FINANCIAL_SERVICES
Document Date
March 19, 2026
Renewal Info
Standard venture capital investment agreements that may be amended by mutual consent under University procedures; no defined renewal date.
More from ENEXA BIO INC
Related Contracts
University of Michigan Commercialization Agreements Nov 2025
APPROVEDUniversity of Michigan Regents Minutes October 2025
APPROVEDMore from University Of Michigan-Ann Arbor
University of Michigan Board of Regents Minutes 2026-03-19
University of Michigan Board of Regents Minutes 2026-03-19
University of Michigan Board of Regents Minutes 2026-03-19
University of Michigan Board of Regents Minutes 2026-03-19
University of Michigan Regents Special Meeting Minutes January 2026
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.